We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

32 hedge funds and large institutions have $3.28M invested in Zomedica Corp. in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 2

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

14% more funds holding

Funds holding: 28 → 32 (+4)

45% less capital invested

Capital invested by funds: $5.94M → $3.28M (-$2.66M)

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
10
Reduced
2
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$387K
2
Millennium Management
Millennium Management
New York
+$260K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$243K
4
WG
Winton Group
United Kingdom
+$98.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$82K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$221K
2
CCFM
Clear Creek Financial Management
Washington
-$95K
3
Barclays
Barclays
United Kingdom
-$84.7K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$19.2K
5
ECM
ETrade Capital Management
Virginia
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
1
Cambridge Investment Research Advisors
Iowa
$1.35M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.19M +$387K +2,811,810 +35%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$199K +$243K +1,764,477 +3,417%
Citadel Advisors
4
Citadel Advisors
Florida
$125K +$82K +595,252 +111%
Northern Trust
5
Northern Trust
Illinois
$93K +$19.6K +142,040 +20%
WG
6
Winton Group
United Kingdom
$79K +$98.9K +717,882 New
SM
7
Sabby Management
Florida
$52K +$64.8K +470,548 New
Two Sigma Investments
8
Two Sigma Investments
New York
$33K +$41.8K +303,011 New
JP Morgan Chase
9
JP Morgan Chase
New York
$29K +$39.4K +285,800 New
Jane Street
10
Jane Street
New York
$25K +$30.8K +223,538 New
Commonwealth Equity Services
11
Commonwealth Equity Services
Massachusetts
$25K +$31.4K +228,000 New
RFA
12
Reilly Financial Advisors
California
$19K +$15.5K +112,431 +189%
UBS Group
13
UBS Group
Switzerland
$12K +$6.98K +50,665 +92%
Victory Capital Management
14
Victory Capital Management
Texas
$9K +$7.09K +51,478 +161%
TSS
15
Two Sigma Securities
New York
$7K +$9.07K +65,821 New
JA
16
JVL Associates
Michigan
$6K – – –
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$5K -$19.2K -139,583 -75%
SPC
18
Sigma Planning Corp
Michigan
$5K +$6.06K +44,000 New
Osaic Holdings
19
Osaic Holdings
Arizona
$4K +$1.53K +11,100 +43%
RIS
20
Retirement Income Solutions
Michigan
$3K – – –
Creative Planning
21
Creative Planning
Kansas
$2K +$1.38K +10,000 +100%
SFA
22
Sequoia Financial Advisors
Ohio
$2K +$2.07K +15,000 New
TCA
23
Transcend Capital Advisors
New Jersey
$2K +$2.76K +20,000 New
TFS
24
Thoroughbred Financial Services
Tennessee
$2K +$2.89K +21,000 New
Morgan Stanley
25
Morgan Stanley
New York
$2K +$2.98K +21,605 New
1
2

ZOM Hedge Fund Activity: Q3 2020 in Review

32 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2020, worth a combined $3.28M — down 45% from $5.94M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ZOM positions and 9 closed out — a net gain of 4 holders — while 10 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $387K. The largest seller was BlackRock, exiting entirely with an estimated $221K sold.

  • 32 institutional investors held Zomedica Corp. (ZOM) as of Q3 2020, up from 28 in Q2 2020.
  • Funds reported $3.28M of Zomedica Corp. stock for Q3 2020, down 45% quarter-over-quarter.
  • 13 funds opened new Zomedica Corp. positions in Q3 2020 and 9 closed out, a net change of +4 holders.
  • The largest Zomedica Corp. buyer in Q3 2020 was Vanguard Group, an estimated $387K added.
  • The largest Zomedica Corp. seller in Q3 2020 was BlackRock, an estimated $221K sold.

Based on aggregated 13F filings for Q3 2020.